PubMed Health⌕ Search

PubMed · 12803825

An asymptotic partial correlation test for the Goodman-Kruskal lambda.

Abstract

Goodman and Kruskal introduced a measure of predictive association when predicting the category of a variable A from a category of a variable B. This measure, denoted lambda, is the asymmetric proportional reduction in error measure in predicting an individual's A category that can be eliminated by using knowledge of the B classification. It takes values on the unit interval, with a zero value meaning no predictive gain, while a value of unity indicates a perfect predictive association between A and B. A test of H(0): lambda = 0 versus H(1): lambda > 0 is analogous to a test for the significance of the correlation coefficient. A test of the partial lambda coefficient, which is analogous to a test of the partial correlation coefficient, answers the question of whether knowledge of an additional third (or higher) classification or categorical variable results in a significant increase in predicting the variable A. Suich and Turek developed an exact test for the partial lambda coefficient, but only for the situation where the predicted categorical variable A is dichotomous. The present paper completes the previous work by developing an asymptotic test where the predicted category A is any polytomous variable.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ronald C Suich, Richard J Turek. 2003. An asymptotic partial correlation test for the Goodman-Kruskal lambda.. https://doi.org/10.1348/000711003321645377

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗